Simplex Trading’s Castle Biosciences CSTL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,512
Closed -$48.7K 8800
2025
Q3
$34K Buy
+1,512
New +$30.7K ﹤0.01% 6836
2025
Q2
Sell
-97
Closed -$1.8K 8799
2025
Q1
$1K Sell
97
-2,967
-97% -$73.5K ﹤0.01% 8177
2024
Q4
$81K Sell
3,064
-8,940
-74% -$272K ﹤0.01% 5376
2024
Q3
$342K Buy
+12,004
New +$306K ﹤0.01% 3996
2024
Q2
Sell
-6
Closed -$134 8930
2024
Q1
$0 Buy
+6
New +$131 ﹤0.01% 8987
2023
Q4
Sell
-260
Closed -$4.58K 8927
2023
Q3
$4K Buy
+260
New +$4.55K ﹤0.01% 7740
2023
Q2
Sell
-3,138
Closed -$63.6K 9113
2023
Q1
$71K Buy
+3,138
New +$76.7K ﹤0.01% 5521
2022
Q4
Sell
-8,968
Closed -$208K 9365
2022
Q3
$233K Buy
8,968
+8,022
+848% +$225K ﹤0.01% 4411
2022
Q2
$20K Buy
+946
New +$22K ﹤0.01% 7600
2022
Q1
Sell
-177
Closed -$7.31K 10526
2021
Q4
$7K Sell
177
-1,443
-89% -$75.4K ﹤0.01% 9282
2021
Q3
$115K Hold
1,620
﹤0.01% 6420
2021
Q2
$118K Buy
+1,620
New +$107K ﹤0.01% 6485
2020
Q4
Sell
-138
Closed -$7.48K 8435
2020
Q3
$7K Sell
138
-10
-7% -$445 ﹤0.01% 6945
2020
Q2
$5K Buy
+148
New +$5.06K ﹤0.01% 6958

Other funds holding CSTL

Simplex Trading's CSTL Position: Q4 2025 in Review

Simplex Trading sold out of Castle Biosciences (CSTL) in Q4 2025, closing a stake of 1,512 shares — an estimated $48.7K sold.

Simplex Trading first reported a position in CSTL in Q2 2020 and held it in 14 quarters. The position peaked at $342K in Q3 2024. 194 funds tracked by Wall St. Rank hold CSTL as of Q4 2025.

  • Simplex Trading reported no remaining Castle Biosciences position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 1,512 Castle Biosciences shares in Q4 2025, an estimated $48.7K.
  • Simplex Trading first reported a position in Castle Biosciences in Q2 2020 and held it in 14 quarters.
  • Simplex Trading's Castle Biosciences position peaked at $342K in Q3 2024.
  • 194 funds tracked by Wall St. Rank held Castle Biosciences as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.